News
All news
Read the latest news and views from Lymphoma Action.
Use the drop down filter to find the most relevant news for you.
More treatment options for DLBCL, Burkitt lymphoma and CLL
The European Medicines Agency has extended the licensed indications for two lymphoma treatments: rituximab and venetoclax.
People with low-risk, high-grade B-cell lymphoma may need fewer cycles of chemotherapy
The FLYER study found that four cycles of R-CHOP was no less effective than six cycles in people with stage 1 or 2 high-grade B-cell lymphoma and no risk factors.
Our Helpline Services are here for you #TimeToTalk
On Time to Talk Day, our Information and Support Officers encourage anyone affected by lymphoma to contact our Helpline Services if they need someone to talk to.
Raise awareness of lymphoma on World Cancer Day 2020
Today marks the 20th anniversary of World Cancer Day – a global movement to raise awareness and understanding of cancer and to ensure that cancer treatment and care is equal for all.
Bucks singer organises concert to support our work
Sara Kalic presents an evening of classical song in Thame on Saturday 8 February.
Acalabrutinib shows promise in Waldenström’s macroglobulinaemia
Phase 2 trial finds that acalabrutinib is active and well tolerated in people with Waldenström’s macroglobulinaemia
Polatuzumab vedotin improves outcomes for people with relapsed or refractory DLBCL
Promising results published in the Journal of Clinical Oncology in November.
Take part in the Lymphoma Coalition 2020 Global Patient Survey
We want to hear from you! Please share your experiences in this new survey.
New treatment for T-cell skin lymphoma approved in Scotland
Brentuximab vedotin (Adcetris®) is now available on the NHS in Scotland for adults with some advanced T-cell skin lymphomas.